Lipoprotein(a): Shining a new light on atherosclerotic cardiovascular disease

Tuesday, July 29
11:30 a.m. - 12:30 p.m.
Exhibit Hall Theater #2
Sponsored by Roche

Overview

Experience the compelling journey of Misty Votaw as she navigates life with elevated Lp(a), a genetically inheritable risk factor for atherosclerotic cardiovascular disease (ASCVD). Misty will share pivotal moments leading to her diagnosis, emphasizing the profound impact on her and her family. Dr. Leslie Donato will underscore the critical role of Lp(a) in ASCVD risk assessment, stressing the urgency for heightened awareness among clinicians and laboratory professionals. Participants will gain valuable insights into the significance of Lp(a) in ASCVD, explore actionable steps for patients and anticipate future advancements in Lp(a) management. This presentation blends scientific acumen with personal narrative to foster a deeper understanding and awareness.

Moderator

Alexander Fohl, PharmD,
Scientific Partner, Roche Diagnostics

Speakers

Leslie Donato, PhD
Board-Certified Clinical Chemist and Assistant Professor in the Department of Laboratory Medicine and Pathology, Mayo Clinic

Misty Votaw
Patient Ambassador, Family Heart

Explore the full ADLM 2025 Scientific Program Online

Browse by day, topic, type, and more to discover the latest in lab medicine in ADLM 2025 Plenaries, Scientific Sessions, Roundtables, University Courses, and special events.

Claim ACCENT & CME Credit

ADLM 2025 attendees that are eligible to claim credits, must do so by October 31. 

Advertisement
Advertisement